<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-129784</identifier>
<setSpec>0304-5013</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Early screening of gestational diabetes and macrosomy</dc:title>
<dc:description xml:lang="en">Gestational diabetes (GD), which has a prevalence of 9%, is associated with high maternal and perinatal morbidity. Early diagnosis and treatment of maternal hyperglycemia reduce the risk of macrosomia and the associated intrapartum complications. Risk factors for GD can be identified in the first trimester from maternal history (age, obesity, previous macrosomia or GD, family history of diabetes), biochemical markers (adiponectin, sex hormone-binding globuline and others), and biophysical markers (arteriography, visceral adiposity). Risk factors for macrosomia include obesity and diabetes in the maternal history, pregnancy associated plasma protein-A and free &amp;#946; subunit of human chorionic gonadotropin as biochemical markers, and nuchal translucency and uterine artery Doppler as biophysical markers. Prediction models combining maternal history, biochemical and biophysical markers can achieve a detection rate of 65% and 35% for GD and macrosomia, respectively, with a false positive rate of 10% (AU)</dc:description>
<dc:creator>Plasencia, Walter</dc:creator>
<dc:creator>Maiz, Nerea</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La diabetes gestacional (DG), con una prevalencia de un 9%, se asocia a una elevada morbilidad materna y perinatal. El diagnóstico y el tratamiento precoz de la hiperglucemia materna reducen el riesgo de macrosomía fetal y sus complicaciones intraparto. En el primer trimestre se puede identificar factores de riesgo de DG de la historia materna (edad, obesidad, macrosomía o DG en gestaciones previas, antecedente familiar de diabetes), marcadores bioquímicos (adiponectina, sex hormone-binding globuline y otros) y marcadores biofísicos (arteriografía, adiposidad visceral). Entre los factores de riesgo de macrosomía destacan la obesidad y la diabetes en la historia materna, pregnancy associated plasma protein-A y fracción libre de la subunidad beta de la gonadotropina coriónica humana como marcadores bioquímicos y la translucencia nucal y Doppler de arterias uterinas como marcadores biofísicos. Combinando los marcadores mediante modelos de predicción, y con una tasa de falsos positivos del 10%, se puede alcanzar una tasa de detección del 65 y el 35% para DG y macrosomía, respectivamente (AU)</dc:description>
<dc:source>Prog. obstet. ginecol. (Ed. impr.);57(10): 472-480, dic. 2014.</dc:source>
<dc:identifier>ibc-129784</dc:identifier>
<dc:title xml:lang="es">Cribado precoz de diabetes gestacional y macrosomía</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d11707^s22031</dc:subject>
<dc:subject>^d28631</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d25123^s22045</dc:subject>
<dc:subject>^d25123^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d23568</dc:subject>
<dc:subject>^d30157^s22032</dc:subject>
<dc:subject>^d19165^s22016</dc:subject>
<dc:subject>^d19165^s22012</dc:subject>
<dc:subject>^d30157^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>201412</dc:date>
</metadata>
</record>
</ibecs-document>
